Evidence map

TrialThe Journal of clinical endocrinology and metabolism2015

Dapagliflozin lowers plasma glucose concentration and improves β-cell function.

Aurora Merovci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

90 papers cite itlatest 60 shown

2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25710563